SORRENTINO, SABATO
 Distribuzione geografica
Continente #
AS - Asia 984
NA - Nord America 944
EU - Europa 427
SA - Sud America 170
AF - Africa 22
OC - Oceania 1
Totale 2.548
Nazione #
US - Stati Uniti d'America 902
SG - Singapore 477
CN - Cina 227
IT - Italia 154
BR - Brasile 140
IN - India 100
VN - Vietnam 99
DE - Germania 64
SE - Svezia 42
GB - Regno Unito 39
NL - Olanda 37
FI - Finlandia 35
CA - Canada 23
HK - Hong Kong 23
IQ - Iraq 14
MX - Messico 14
ZA - Sudafrica 11
AR - Argentina 10
FR - Francia 10
BD - Bangladesh 7
ID - Indonesia 7
PL - Polonia 7
AT - Austria 6
EC - Ecuador 6
JP - Giappone 6
CZ - Repubblica Ceca 5
CO - Colombia 4
ES - Italia 4
PY - Paraguay 4
RO - Romania 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
TR - Turchia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
UA - Ucraina 3
UY - Uruguay 3
CH - Svizzera 2
ET - Etiopia 2
KE - Kenya 2
LT - Lituania 2
MA - Marocco 2
PK - Pakistan 2
PT - Portogallo 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
BB - Barbados 1
BH - Bahrain 1
CL - Cile 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
HN - Honduras 1
JO - Giordania 1
KZ - Kazakistan 1
MY - Malesia 1
NR - Nauru 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TL - Timor Orientale 1
Totale 2.548
Città #
Singapore 216
Chandler 103
Santa Clara 98
Bengaluru 92
Hefei 91
Dallas 75
Ashburn 71
Milan 51
Munich 44
Beijing 38
Ho Chi Minh City 37
Lawrence 34
Princeton 34
Chicago 25
London 24
Hong Kong 22
Helsinki 21
Wilmington 20
New York 19
São Paulo 19
Hanoi 17
Los Angeles 17
Turku 14
Amsterdam 11
Assago 10
Brooklyn 10
Boardman 9
Ottawa 9
Rome 9
Atlanta 8
Johannesburg 8
San Francisco 8
Shanghai 8
Stockholm 8
Des Moines 7
Haiphong 7
Mexico City 7
Catanzaro 6
Redmond 6
Warsaw 6
Baghdad 5
Hanover 5
Tokyo 5
Charlotte 4
Da Nang 4
Denver 4
Erbil 4
Madison 4
Montreal 4
Olomouc 4
Tashkent 4
Ankara 3
Augusta 3
Bari 3
Boston 3
Brasília 3
Buffalo 3
Campinas 3
Chennai 3
Ferrara 3
Guangzhou 3
Jakarta 3
Macaé 3
Ninh Bình 3
Porto Alegre 3
Portofino 3
Quito 3
Redwood City 3
Sorocaba 3
São José dos Campos 3
The Dalles 3
Thái Nguyên 3
Topeka 3
Uberaba 3
Addis Ababa 2
Agawam 2
Barbacena 2
Berazategui 2
Biên Hòa 2
Bocale 2
Buriticupu 2
Bắc Giang 2
Bến Cầu 2
Can Tho 2
Cape Town 2
Ciudad del Este 2
Columbus 2
Cosenza 2
Curitiba 2
Hasselt 2
Horia 2
Houston 2
Huntington 2
Jacksonville 2
Jeddah 2
Juneau 2
Manchester 2
Miami 2
Montalto Uffugo 2
Montevideo 2
Totale 1.487
Nome #
Empagliflozin prevents doxorubicin-induced myocardial dysfunction 70
Hand Laser Perfusion Imaging to Assess Radial Artery Patency: A Pilot Study. 66
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials 56
Hindlimb Ischemia Impairs Endothelial Recovery and Increases Neointimal Proliferation in the Carotid Artery. 53
The duration of balloon inflation affects the luminal diameter of coronary segments after Bioresorbable Vascular Scaffolds deployment 52
Indirect Comparison of the Efficacy and Safety of Alirocumab and Evolocumab: A Systematic Review and Network Meta-Analysis 52
B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity-A Meta-Analysis 52
Flow-Responsive Noncoding RNAs in the Vascular System: Basic Mechanisms for the Clinician 48
Early hemodynamic impact of SGLT2 inhibitors in overweight cardiometabolic heart failure: beyond fluid offloading to vascular adaptation– a preliminary report 47
Mir-16 Modulates Endothelial Dysfunction After Balloon Injury in a Rat Model of Chronic Peripheral Ischemia. 47
Instantaneous wave-Free Ratio (iFR) and Gradient (iFG): new promising adenosine-independent alternative to fractional flow reserve. Preliminary results from the FORECAST Study. 46
Down-Regulation of miR-23/27/24 Clusters by TGF-beta 1 Signalling Induces Phenotypic Switching of Vascular Smooth Muscle Cells in vitro and in Response to Vascular Injury in vivo. 45
Dual anti-thrombotic treatment with direct anticoagulants improves clinical outcomes in patients with Atrial Fibrillation with ACS or undergoing PCI. A systematic review and meta-analysis 45
Corrigendum to “miR-125a-5p Modulates Phenotypic Switch of Vascular Smooth Muscle Cells by Targeting ETS-1” (J. Mol. Biol. Jun 16 2017; 429(12):1817–1828) (S002228361730222X) (10.1016/j.jmb.2017.05.008) 44
Predictors of outcomes in patients with mitral regurgitation undergoing percutaneous valve repair 43
The Role of Mir-16 on Endothelial Dysfunction in Rat with Atherosclerotic Diet with a Chronic Model of Femoral Artery Occlusion and Carotid Balloon Injury. 41
Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement 41
New Antithrombotic Strategies and Coronary Stent Technologies for Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention 41
MicroRNA-1 Downregulation Increases Connexin 43 Displacement and Induces Ventricular Tachyarrhythmias in Rodent Hypertrophic Hearts. 40
Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 40
Single Versus Dual Antiplatelet Therapy Following TAVR: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 40
Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes 40
Mechanical heart valves between myths and new evidence: a systematic review and meta-analysis 39
Incidence, Predictors, and Prognostic Impact of Neurologic Events After TAVR According to VARC-3 Criteria 39
Delayed sudden radial artery rupture after left transradial coronary catheterization: a case report. 39
The instantaneous wave-Free Ratio (iFR) for evaluation of non culprit lesions in patients with Acute Coronary Syndrome and multivessel disease. 38
Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients 38
Direct Oral Anticoagulants in Patients With Active Cancer 36
Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo 36
[Debate on dual pathway inhibition: Antiplatelet and anticoagulant therapies in patients undergoing percutaneous coronary intervention at high risk for recurrent ischemic events. Focus on anticoagulation-based strategies] 35
Acute expansion of nitinol-based self-expandable device in patients undergoing transfemoral aortic valve implantation 33
Non-invasive myocardial work is reduced during transient acute coronary occlusion 33
Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices 32
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor. 32
Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients for the Treatment of Severe Aortic Stenosis 32
Non-Invasive Myocardial Work in Patients with Severe Aortic Stenosis 32
Prediction of Significant Coronary Artery Disease Through Advanced Echocardiography: Role of Non-invasive Myocardial Work 32
The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function 30
Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials 30
Risk of Bleeding in Elderly Patients Undergoing Transcatheter Aortic Valve Implantation or Surgical Aortic Valve Replacement 28
Cellular and Molecular Mechanisms Underlying Tricuspid Valve Development and Disease 28
Reliability of Instantaneous Wave-Free Ratio (iFR) for the Evaluation of Left Main Coronary Artery Lesions 27
Clinical and Procedural Outcomes of 5-French versus 6-French Sheaths in Transradial Coronary Interventions 26
Simultaneous Radial and Ipsilateral Ulnar Artery Compression versus Isolated Radial Artery Compression after Conventional Radial Access for Coronary Angiography and/or Intervention: A Systematic Review and Meta-Analysis 26
Incidence and outcomes of transient new-onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis 25
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation 25
Stent Thrombosis After Percutaneous Coronary Intervention 25
Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: Not all countries are equal 25
Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents 24
Small‐vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus‐eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post‐Approval studies 23
Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence 23
Standard Versus Ultrasound-Guided Cannulation of the Femoral Artery in Patients Undergoing Invasive Procedures: A Meta-Analysis of Randomized Controlled Trials 23
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention 22
Acute Kidney Injury After Transcatheter Aortic Valve Replacement Mediates the Effect of Chronic Kidney Disease 22
Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention 21
Rationale for Early Administration of PCSK9 Inhibitors in Acute Coronary Syndrome 21
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk 21
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 20
The link between anemia and adverse outcomes in patients with acute coronary syndrome 19
Cerebral Embolic Protection During TAVR 19
The prevalence, predictors and outcomes of guideline‐directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry 19
Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 19
Effect of valve design and anticoagulation strategy on 30‐day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 19
Unmet Needs in TAVR: Conduction Disturbances and Management of Coronary Artery Disease 19
Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies 18
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction 18
The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO‐3 trial 18
Bioprosthetic leaflet thrombosis and reduced leaflet motion after transcatheter aortic valve replacement: A systematic review and meta-analysis 18
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial 17
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta‐analysis 17
Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease 17
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study 16
Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 16
Clinical manifestations and outcomes of coronavirus disease‐19 in heart transplant recipients: a multicentre case series with a systematic review and meta‐analysis 16
Paravalvular Leak 16
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention 16
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention 16
Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention 16
Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention 16
Common Calcified Femoral Artery Rupture After Intravascular Lithotripsy for TAVR Implantation 16
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 16
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies 15
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry 15
Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention 15
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry) 15
Effect of SGLT2 inhibitors on cardiac structure and function assessed by cardiac magnetic resonance: a systematic review and meta-analysis 15
White blood cell count and clinical outcomes after left main coronary artery revascularization: insights from the EXCEL trial 14
Limitations of Current Risk Scoring in Real World Populations: The Importance of External Validation 14
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age 13
Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiative 13
The Telecardiology Revolution: From Emergency Management to Daily Clinical Practice 13
Impact of pre‐existing or new‐onset atrial fibrillation on 30‐day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 13
Effect of Transcatheter Aortic Valve Implantation on Non-Invasive Myocardial Work Parameters: A Systematic Review and Meta-Analysis 12
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 12
Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN‐TAVI registry 12
Artificial Intelligence in Cardiac Electrophysiology: A Clinically Oriented Review with Engineering Primers 9
Drug-coated balloons and hybrid strategies versus drug-eluting stents in chronic total occlusions: a systematic review and meta-analysis 7
Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention 6
Comprehensive insights into peripheral artery disease: an overview from the working groups of pathogenesis of atherosclerosis and thrombosis of the Italian Society of Cardiology 5
Vascular Complications in Patients Undergoing Transcatheter Aortic Valve Replacement With Contemporary Devices 5
Totale 2.710
Categoria #
all - tutte 29.604
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.604


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 4 5 6 5 3 2 6
2021/2022117 0 0 3 29 10 4 0 27 11 13 17 3
2022/2023352 74 12 40 12 45 28 3 26 52 21 30 9
2023/2024233 28 22 12 12 3 42 0 13 64 5 18 14
2024/2025827 96 35 34 22 60 135 43 16 79 15 117 175
2025/20261.094 99 239 151 274 290 41 0 0 0 0 0 0
Totale 2.731